Concepedia

Yan-jun Zhong

YZ

Statistics

Publications

4

Citations

105

H-Index

4

Active since

2011

Affiliations

Zhongnan Hospital of Wuhan University(Current)

Wuhan University

Hubei Cancer Hospital

Yan-jun Zhong is an author at Zhongnan Hospital of Wuhan University specializing in chemotherapy, pharmacology, and cathepsin-activated prodrugs.

Publications per year

2011–2014

4

Publications

4

Cathepsin B cleavable novel prodrug Ac‐Phe‐Lys‐PABC‐ADM enhances efficacy at reduced toxicity in treating gastric cancer peritoneal carcinomatosis

Li‐Hua Shao, Shaoping Liu, Jinxuan Hou et al. · Cancer · 2011 · 52 citations · Full text

, , +14

Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study

Qun Wang, Yan-jun Zhong, Jingping Yuan et al. · Journal of Translational Medicine · 2013 · 31 citations · Full text

, , +17

Synthesis, identification and in vivo studies of tumor-targeting agent peptide doxorubicin (PDOX) to treat peritoneal carcinomatosis of gastric cancer with similar efficacy but reduced toxicity

Li Tang, Rui Duan, Yan-jun Zhong et al. · Molecular Cancer · 2014 · 12 citations · Full text

, , +17

Anticancer effects of Ac-Phe-Lys-PABC-doxorubicin via mitochondria-centered apoptosis involving reactive oxidative stress and the ERK1/2 signaling pathway in MGC-803 cells

Yan-jun Zhong, SHAO-PING LIU, Raymond A. Firestone et al. · Oncology Reports · 2013 · 10 citations · Full text

, , +17

1–4 of 4